Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results
Katharina Kriechbaum(Medical University of Vienna), Ursula Schmidt‐Erfurth(Medical University of Vienna), Sonja Prager(Medical University of Vienna), Georgios Mylonas(Medical University of Vienna), Marion Funk(Medical University of Vienna), Michael Kundi(Medical University of Vienna), Christoph Scholda(Trend Micro (Japan)), Gregor Rainer(Medical University of Vienna)
Cited by 54
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496
Diabetic Cataract—Pathogenesis, Epidemiology and Treatment
|Journal of Ophthalmology|2010|408
Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria
|Food and Chemical Toxicology|2007|344